[Federal Register Volume 65, Number 203 (Thursday, October 19, 2000)]
[Notices]
[Page 62722]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-26899]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Radiological Devices Panel of the Medical Devices Advisory 
Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). At least one 
portion of the meeting will be closed to the public.
    Name of Committee: Radiological Devices Panel of the Medical 
Devices Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on November 6, 2000, 10 
a.m. to 4:30 p.m.
    Location: Corporate Bldg., conference room 020B, 9200 Corporate 
Blvd., Rockville, MD.
    Contact Person: Robert J. Doyle, Center for Devices and 
Radiological Health (HFZ-470), Food and Drug Administration, 9200 
Corporate Blvd., Rockville, MD 20850, 301-594-1212, or FDA Advisory 
Committee Information Line, 1-800-741-8138 (301-443-0572 in the 
Washington, DC area), code 12526. Please call the Information Line for 
up-to-date information on this meeting.
    Agenda: The committee will discuss, make recommendations, and vote 
on a premarket approval application for an embolic radiation therapy 
device.
    Procedure: On November 6, 2000, from 10 a.m. to 12:30 p.m., and 
from 1 p.m. to 4:30 p.m., the meeting is open to the public. Interested 
persons may present data, information, or views, orally or in writing, 
on issues pending before the committee. Written submissions may be made 
to the contact person by October 26, 2000. Oral presentations from the 
public will be scheduled between approximately 10:15 a.m. and 10:45 
a.m., and for an additional 30 minutes near the end of the committee 
deliberations. Time allotted for each presentation may be limited. 
Those desiring to make formal oral presentations should notify the 
contact person before October 26, 2000, and submit a brief statement of 
the general nature of the evidence or arguments they wish to present, 
the names and addresses of proposed participants, and an indication of 
the approximate time requested to make their presentation.
    Closed Committee Deliberations: On November 6, 2000, from 12:30 
p.m. to 1 p.m., the meeting will be closed to the public to permit 
discussion and review of trade secret and/or confidential commercial 
information (5 U.S.C. 552b(c)(4)) regarding pending and future agency 
issues.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: October 13, 2000.
Linda A. Suydam,
Senior Associate Commissioner.
[FR Doc. 00-26899 Filed 10-18-00; 8:45 am]
BILLING CODE 4160-01-F